Loring Wolcott & Coolidge Fiduciary Advisors LLP Haleon PLC Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q2 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Haleon PLC stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 950 shares of HLN stock, worth $8,502. This represents 0.0% of its overall portfolio holdings.
Number of Shares
950
Previous 950
-0.0%
Holding current value
$8,502
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HLN
# of Institutions
705Shares Held
468MCall Options Held
158KPut Options Held
0-
Dodge & Cox San Francisco, CA155MShares$1.39 Billion0.97% of portfolio
-
Clearbridge Investments, LLC New York, NY31.4MShares$281 Million0.28% of portfolio
-
Harding Loevner LP Bridgewater, NJ22.6MShares$202 Million1.62% of portfolio
-
Morgan Stanley New York, NY17.7MShares$159 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA16.7MShares$149 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $41.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...